Inactive Instrument

Calendar Corcept Therapeutics Nasdaq

Equities

Chart calendar Corcept Therapeutics

674c0d.JepXDHbMzl8kjRs1vzB56ZpYkEcmOibyiS2RRHNeogg.EKBgVQT-ojx8tFZ62Gkf3fAc6DdUCV-D1l7JHjEp6F8S2h98Hv20K37cTg~a132a9fd2ff9608cd44cfa755d7106ce

Upcoming events on Corcept Therapeutics

17/05/2024 15:30 Annual General Meeting
30/07/2024 Q2 2024 Earnings Release (Projected)
29/10/2024 Q3 2024 Earnings Release (Projected)
11/02/2025 Q4 2024 Earnings Release (Projected)
29/04/2025 Q1 2025 Earnings Release (Projected)

Past events on Corcept Therapeutics

01/05/2024 22:00 Q1 2024 Earnings Call
01/05/2024 21:05 Q1 2024 Earnings Release
15/02/2024 22:00 Q4 2023 Earnings Call
15/02/2024 21:05 Q4 2023 Earnings Release
01/11/2023 21:00 Q3 2023 Earnings Call
01/11/2023 20:05 Q3 2023 Earnings Release
02/08/2023 22:00 Q2 2023 Earnings Call
02/08/2023 21:05 Q2 2023 Earnings Release
19/05/2023 15:30 Annual General Meeting
03/05/2023 22:00 Q1 2023 Earnings Call
03/05/2023 21:05 Q1 2023 Earnings Release
15/03/2023 Jefferies Biotech on the Bay Summit
28/02/2023 22:00 Q4 2022 Earnings Call
28/02/2023 21:05 Q4 2022 Earnings Release
16/02/2023 20:00 SVB Securities Global Biopharma Conference
03/11/2022 21:00 Q3 2022 Earnings Call
03/11/2022 20:05 Q3 2022 Earnings Release
03/08/2022 22:00 Interim 2022 Earnings Call
03/08/2022 21:05 Interim 2022 Earnings Release
06/06/2022 15:00 American Society of Clinical Oncology Meeting

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
307
306
0.02%
354
358
-1.28%
366
368
-0.47%
402
404
-0.5%
482
476
1.28%

632

EBITDA
Million USD
Released
Forecast
Spread
112
116
-3.02%
129
125
3.07%
126
149
-15.93%
156
160
-2.53%
0,00
102
-

137

EBIT
Million USD
Released
Forecast
Spread
112
113
-1.51%
128
123
4.55%
124
131
-5.31%
113
140
-19.59%
107
109
-1.52%

122

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
117
118
-1.24%
132
127
3.29%
125
126
-0.53%
116
127
-8.79%
125
124
0.58%

134

Net income
Million USD
Released
Forecast
Spread
94,2
96,8
-2.67%
106
101
4.74%
113
110
2.53%
101
114
-11.14%
105
104
1.27%

109

EPS
USD
Released
Forecast
Spread
0,77
0,78
-1.28%
0,85
0,81
5.59%
0,89
0,86
3.29%
0,87
0,96
-8.9%
0,94
0,92
1.95%

0,96

Announcement Date20/02/2008/02/2115/02/2228/02/2315/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
93,7
98,6
-4.98%
103
101
2.36%
102
108
-5.43%
103
105
-1.93%
106
105
0.71%
118
110
7.4%
124
120
3.24%
135
129
4.72%
147
141
3.97%

155


162


168


167


173

EBITDA
Million USD
Released
Forecast
Spread
37,8
45,0
-15.96%
42,2
43,8
-3.76%
42,7
42,5
0.43%
33,2
37,2
-10.74%
26,2
24,0
9.03%
29,8
19,3
54.24%
























EBIT
Million USD
Released
Forecast
Spread
26,8
36,6
-26.84%
31,4
35,7
-11.93%
31,9
36,7
-12.91%
22,5
37,2
-39.47%
14,9
25,5
-41.71%
29,6
18,2
62.43%
31,2
26,9
15.77%
31,7
33,3
-4.94%
29,5
27,8
6.03%

29,1


31,0


33,9


34,0


37,9

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
26,8
35,7
-24.82%
32,1
32,4
-1.19%
33,0
33,4
-1.18%
24,3
35,5
-31.58%
18,4
24,9
-25.97%
32,9
19,7
66.88%
36,4
28,7
26.6%
36,8
36,1
1.97%
35,0
30,6
14.32%

31,7


33,5


35,8


37,3


41,2

Net income
Million USD
Released
Forecast
Spread
22,8
28,3
-19.54%
27,4
26,1
4.95%
34,6
27,8
24.33%
16,6
29,2
-43.27%
15,8
21,1
-25.23%
27,4
17,2
59.26%
31,2
24,4
27.88%
31,1
29,6
5.25%
27,5
25,3
8.97%

26,2


27,7


29,8


29,6


32,7

EPS
USD
Released
Forecast
Spread
0,20
0,23
-13.79%
0,24
0,21
12.15%
0,30
0,23
30.43%
0,14
0,23
-37.78%
0,14
0,19
-27.58%
0,25
0,15
66.67%
0,28
0,22
28.25%
0,28
0,26
8.53%
0,25
0,22
13.64%

0,23


0,24


0,26


0,28


0,31

Announcement Date05/05/2203/08/2203/11/2228/02/2303/05/2302/08/2301/11/2315/02/2401/05/24-----
  1. Stock Market
  2. Equities
  3. CORT Stock
  4. Stock
  5. Calendar Corcept Therapeutics